INTENSIVE INTRAVENOUS METHOTREXATE AND MERCAPTOPURINE TREATMENT OF HIGHER-RISK NON-T, NON-B ACUTE LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY

被引：72
作者：
CAMITTA, B
MAHONEY, D
LEVENTHAL, B
LAUER, SJ
SHUSTER, JJ
ADAIR, S
CIVIN, C
MUNOZ, L
STEUBER, P
STROTHER, D
KAMEN, BA
机构：
[1] MED COLL WISCONSIN,MIDWEST CHILDRENS CANC CTR,DEPT PEDIAT,MILWAUKEE,WI 53226
[2] CHILDRENS HOSP WISCONSIN,MILWAUKEE,WI 53201
[3] WEBSTER CLIN,GREEN BAY,WI
[4] ST VINCENTS HOSP,GREEN BAY,WI
[5] BAYLOR COLL MED,HOUSTON,TX 77030
[6] UNIV TEXAS,SW MED CTR,DALLAS,TX
[7] JOHNS HOPKINS UNIV,CTR ONCOL,BALTIMORE,MD 21205
[8] PEDIAT ONCOL GRP,STAT OFF,GAINESVILLE,FL
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1994年 / 12卷 / 07期
关键词：
D O I：
10.1200/JCO.1994.12.7.1383
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1383 / 1389
页数：7
相关论文
共 29 条
[1]   HIGH-DOSE METHOTREXATE IMPROVES CLINICAL OUTCOME IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - ST-JUDE TOTAL THERAPY STUDY [J].
ABROMOWITCH, M ;
OCHS, J ;
PUI, CH ;
KALWINSKY, D ;
RIVERA, GK ;
FAIRCLOUGH, D ;
LOOK, AT ;
HUSTU, HO ;
MURPHY, SB ;
EVANS, WE ;
DAHL, GV ;
BOWMAN, WP .
MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (05) :297-303
[2]   SEQUENCE-DEPENDENT, TIME-DEPENDENT AND DOSE-DEPENDENT SYNERGISM OF METHOTREXATE AND 6-MERCAPTOPURINE IN MALIGNANT HUMAN T-LYMPHOBLASTS [J].
BOKKERINK, JPM ;
BAKKER, MAH ;
HULSCHER, TW ;
DEABREU, RRA ;
SCHRETLEN, EDAM ;
VANLAARHOVEN, JPRM ;
DEBRUYN, CHMM .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (20) :3549-3555
[3]  
BUCHANAN GR, 1990, HEMATOL ONCOL CLIN N, V4, P971
[4]   INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE AND MERCAPTOPURINE THERAPY FOR NON-T, NON-B ACUTE LYMPHOCYTIC-LEUKEMIA OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP STUDY [J].
CAMITTA, B ;
LEVENTHAL, B ;
LAUER, S ;
SHUSTER, JJ ;
ADAIR, S ;
CASPER, J ;
CIVIN, C ;
GRAHAM, M ;
MAHONEY, D ;
MUNOZ, L ;
KIEFER, G ;
KAMEN, B .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) :1539-1544
[5]  
CASPER J, 1992, BLOOD S, V80, pA65
[6]  
EVANS WE, 1991, SEMIN HEMATOL, V28, P15
[7]   CLINICAL PHARMACODYNAMICS OF HIGH-DOSE METHOTREXATE IN ACUTE LYMPHOCYTIC-LEUKEMIA - IDENTIFICATION OF A RELATION BETWEEN CONCENTRATION AND EFFECT [J].
EVANS, WE ;
CROM, WR ;
ABROMOWITCH, M ;
DODGE, R ;
LOOK, AT ;
BOWMAN, WP ;
GEORGE, SL ;
PUI, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (08) :471-477
[8]   MTX CLEARANCE IS MORE IMPORTANT FOR INTERMEDIATE-RISK ALL [J].
EVANS, WE ;
SCHELL, MJ ;
PUI, CH .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) :1115-1116
[9]   COMPARISON OF INTERMEDIATE-DOSE METHOTREXATE WITH CRANIAL IRRADIATION FOR THE POST-INDUCTION TREATMENT OF ACUTE LYMPHOCYTIC-LEUKEMIA IN CHILDREN [J].
FREEMAN, AI ;
WEINBERG, V ;
BRECHER, ML ;
JONES, B ;
GLICKSMAN, AS ;
SINKS, LF ;
WEIL, M ;
PLEUSS, H ;
HANANIAN, J ;
BURGERT, EO ;
GILCHRIST, GS ;
NECHELES, T ;
HARRIS, M ;
KUNG, F ;
PATTERSON, RB ;
MAURER, H ;
LEVENTHAL, B ;
CHEVALIER, L ;
FORMAN, E ;
HOLLAND, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (09) :477-484
[10]   DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY [J].
FREI, E ;
CANELLOS, GP .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :585-594
123